BSX vs DXCM Stock Comparison

Compare BSX and DXCM across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 11, 2026 market close· AIQ score gap 5 points
BSX
Healthcare
vs
DXCM
Healthcare
BSX
Boston Scientific Corporation
Price
$42.98
Day move
-0.28%
AIQ Score
49/100
Best edge
Value
Sector
Healthcare
DXCM
DexCom, Inc.
Leads
Price
$83.03
Day move
-1.75%
AIQ Score
54/100
Best edge
Quality
Sector
Healthcare

What is the main difference between BSX and DXCM?

DXCM leads the current stock comparison as DexCom, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Boston Scientific Corporation vs DexCom, Inc.

Data as of Sep 11, 2026· market close· Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

DXCM leads

DXCM leads by 5 AIQ points, primarily on Quality and Momentum, having only recently taken the lead back from BSX. Wall Street currently favors BSX on target upside.

Fragile: 4 of 6 evidence groups support DXCM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Reversed
BSX

Boston Scientific Corporation

AIQ Score
49/100
AIQ Edge Score
6/10
DXCM

DexCom, Inc.

Leads
AIQ Score
54/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors DXCM over BSX, 54 versus 49 as of Sep 11, 2026. DXCM's advantage is driven primarily by stronger quality and momentum, while BSX holds the stronger value profile. DXCM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BSX. 4 of 6 covered evidence groups favor DXCM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. DXCM lead: Reversed — BSX led by 2 AIQ points 30 sessions ago; DXCM now leads by 5.

Compare Boston Scientific Corporation and DexCom, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price-return comparison using available daily close history.

BSX
-2.5%
DXCM
-37.4%

Total return comparison

Growth of $10,000

BSX $9,749 · DXCM $6,255

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare BSX and DXCM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BSX advantage
0
DXCM advantage
  • Value58 vs 28
    BSX +30
  • Quality67 vs 86
    DXCM +19
  • Momentum23 vs 42
    DXCM +19
  • Risk Resilience41 vs 60
    DXCM +19

4 of 6 evidence groups favor DXCM. DXCM’s edge is concentrated in quality and momentum; BSX keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.

BSX-1 AIQ

Largest factor move: Risk Resilience -2

New signals

  • BB Lower Band Breach bullish, volatility, short horizon
  • 52-Week Low Proximity bearish, risk, long horizon (1.4%)
DXCM+1 AIQ

Largest factor move: Momentum +1

No new signals fired.

DXCM's lead widened by 2 AIQ points in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — BSX and DXCM both carry a full feed there.

The central trade-off

DXCM (DexCom, Inc.): the stronger current systematic profile, led by quality and momentum.

BSX (Boston Scientific Corporation): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 42.3% against 23.1%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

DXCM

DXCM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

DXCM

DXCM on combined revenue and EPS growth.

Value

BSX

BSX on the peer-relative Value factor, by 30 points.

Momentum

DXCM

DXCM on the Momentum factor, by 19 points.

Lower downside

DXCM

DXCM on Risk Resilience, by 19 points.

Analyst upside

BSX

BSX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors DXCM, analyst targets favor BSX. That disagreement is the most useful thing on this page.

MeasureBSXDXCMNote
Implied upside to target+70.1%+5.6%BSX has more room
Target dispersion+68.4%+46.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2014Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor DXCM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreDXCM49 vs 54
FundamentalsDXCMon balancerevenue growth 4.6% vs 9.8%; EPS growth -31.1% vs 25%; TTM ROE 14.9% vs 36.2%; gross margin 71.2% vs 62.5%; operating margin 21.5% vs 22.9% — DXCM takes 4 of 5 decided legs, not all of them
ValuationBSXValue 58 vs 28
TechnicalsDXCMPrice vs 50-day -8.4% vs 1.1%; vs 200-day -34.7% vs 18.6%
Risk ResilienceDXCMRisk Resilience 41 vs 60
Analyst expectationsBSXTarget upside 70.1% vs 5.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BSX and DXCM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DXCM.

How the comparison changed

119 daily snapshots · May 4 Sep 10

DXCM lead: Reversed — BSX led by 2 AIQ points 30 sessions ago; DXCM now leads by 5.

May 4BSX leads above the line · DXCM leads belowSep 10
Today
DXCM +5
49 vs 54
7 sessions ago
DXCM +2
55 vs 57
30 sessions ago
BSX +2
63 vs 61
90 sessions ago
DXCM +3
54 vs 57

The lead changed hands 4 times in this window, most recently on Jul 31 when BSX moved ahead of DXCM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BSXConflicted

2 bullish / 5 bearish / 1 neutral, conflicted

  • Death Cross Active bearish, trend, long horizon (40.53%)
  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
DXCMConflicted

3 bullish / 1 bearish, conflicted

  • Golden Cross Active bullish, trend, long horizon (15.24%)
  • EMA Ribbon Expansion Bullish bullish, trend, medium horizon
  • Uptrend Structure Active bullish, trend, long horizon

DXCM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BSXConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.28%, AIQ -1 points).

DXCMDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.75%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BSX closes the Quality gap — currently 19 points behind, the largest single contributor to DXCM's edge.
  2. 2BSX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3DXCM's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

DXCM leads on balance
MetricBSXDXCM
Revenue growth (YoY)4.6%9.8%
EPS growth (YoY)-31.1%25%
Gross margin71.2%62.5%
Operating margin21.5%22.9%
Return on equity (TTM)14.9%36.2%
Debt to equity0.510.53

Performance

DXCM leads 6 of 6 windows
MetricBSXDXCM
1 week (5 sessions)-10.9%-5.8%
1 month (20 sessions)-16.2%-6.9%
3 months (63 sessions)-10.8%13%
6 months (126 sessions)-38.1%27.4%
Year to date-54.8%27.3%
1 year (252 sessions)-59.8%8.3%

Technicals

DXCM has the stronger structure
MetricBSXDXCM
RSI (14)29.831.5
ADX (14)1725.7
Price vs 50-day-8.4%1.1%
Price vs 200-day-34.7%18.6%
Volatility (1M, annualized)42.3%23.1%

Risk

DXCM is the more resilient
MetricBSXDXCM
Beta0.180.66
Sharpe ratio-2.330.29
Sortino ratio-2.560.4
Max drawdown-60.6%-30.1%
Current drawdown-60.1%-8.5%
Annualized volatility38%41.3%
Value at risk (95%)-3.6%-3.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BSX or DXCM?

On the Algovestiq AIQ Score, DXCM is the stronger of the two as of Sep 11, 2026, scoring 54 against BSX's 49. The edge comes from quality and momentum. BSX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BSX or DXCM the better buy right now?

DXCM carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.

Why does the AIQ Score favor DXCM over BSX?

The composite weights Quality, Value, Momentum and Risk Resilience. BSX leads Value by 30 points; DXCM leads Quality by 19 points; DXCM leads Momentum by 19 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BSX or DXCM?

Analyst price targets imply +70.1% upside for BSX and +5.6% for DXCM, so the Street currently favors BSX. That points the opposite way to the AIQ Score, which favors DXCM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BSX or DXCM?

BSX is the better-valued of the two on the peer-relative Value factor. BSX on the peer-relative Value factor, by 30 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BSX or DXCM?

DXCM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BSX or DXCM?

DXCM on the Momentum factor, by 19 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BSX or DXCM?

DXCM is the more resilient of the two, so the other name carries the higher downside risk. DXCM on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BSX more profitable than DXCM?

The profitability evidence is mixed: gross margin 71.2% vs 62.5%; operating margin 21.5% vs 22.9%; ttm roe 14.9% vs 36.2%. BSX leads on one measure and DXCM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is DXCM's lead over BSX getting stronger or weaker?

DXCM lead: Reversed — BSX led by 2 AIQ points 30 sessions ago; DXCM now leads by 5. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-07-31, when BSX moved ahead of DXCM.

What would change the BSX vs DXCM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BSX closes the Quality gap — currently 19 points behind, the largest single contributor to DXCM's edge; BSX's Death Cross Active resolves — a bearish trend rule currently active against it; DXCM's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about BSX and DXCM?

BSX: 2 bullish / 5 bearish / 1 neutral, conflicted. DXCM: 3 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BSX is Death Cross Active (bearish, long horizon). On DXCM it is Golden Cross Active (bullish, long horizon).

Compare BSX and DXCM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.